Hjem › Interstitielle lungesygdomme › Alabama › Birmingham
Interstitielle lungesygdomme kliniske forsøg i Birmingham, AL
9 studier for Interstitielle lungesygdomme søger deltagere på steder i og omkring Birmingham (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression
RekruttererFase 3
- University of Alabama at Birmingham, Birmingham
LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
RekruttererFase 2
- University of Alabama, Birmingham
A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
RekruttererFase 2
- UAB Lung Health Center, Birmingham
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
Rekrutterer
- University of Alabama at Birmingham, Birmingham
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
RekruttererObservationsstudie
- University of Alabama at Birmingham, Birmingham
Platform Clinical Study for Conquering Scleroderma
RekruttererFase 2
- University of Alabama - Division of Pulmonary and Critical Care Medicine, Birmingham
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
RekruttererObservationsstudie
- University of Alabama - Birmingham, Birmingham
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
RekruttererFase 3
- UAB Lung Health Center, Birmingham
Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis
RekruttererFase 2
- University of Alabama at Birmingham, Birmingham
Interstitielle lungesygdomme forsøg i andre byer
- New York City, NY18 studier
- Philadelphia, PA16 studier
- Los Angeles, CA14 studier
- Kansas City, KS13 studier
- Durham, NC13 studier
- Charleston, SC13 studier
- Chicago, IL12 studier
- Houston, TX12 studier
- Ann Arbor, MI11 studier
- Aurora, CO11 studier
- Phoenix, AZ9 studier
- Salt Lake City, UT9 studier
Andre studier i Birmingham
- Kræft (alle typer)30 studier
- Brystkræft24 studier
- Overvægt23 studier
- Ægstockræft23 studier
- Ikke-småcellet lungecancer22 studier
- Akut myeloid leukæmi21 studier
- Multipelt myelom18 studier
- KOL17 studier
- Kardiovaskulær sygdom17 studier
- Overvægt16 studier
- Livmoderslimhindekræft16 studier
- Type 2-diabetes16 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.